4.7 Article

Induction of protein citrullination and auto-antibodies production in murine exposed to nickel

期刊

SCIENTIFIC REPORTS
卷 8, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41598-017-19068-1

关键词

-

资金

  1. CRANN/AMBER (SFI)
  2. EU FP7 NAMDIATREAM project [NMP-2009-LARGE-3-246479]
  3. EU FP7 MULTIFUN project [NMP-2010-LARGE-4-242943]
  4. NIH grant FP7 project NANOMMUNE [EC-FP-7-NANOMMUNE-214281]

向作者/读者索取更多资源

Citrullination, or the post-translational deimination of polypeptide-bound arginine, is involved in several pathological processes in the body, including autoimmunity and tumorigenesis. Recent studies have shown that nanomaterials can trigger protein citrullination, which might constitute a common pathogenic link to disease development. Here we demonstrated auto-antibody production in serum of nanomaterials-treated mice. Citrullination-associated phenomena and PAD levels were found to be elevated in nanomaterials -treated cell lines as well as in the spleen, kidneys and lymph nodes of mice, suggesting a systemic response to nanomaterials injection, and validated in human pleural and pericardial malignant mesothelioma (MM) samples. The observed systemic responses in mice exposed to nanomaterials support the evidence linking exposure to environmental factors with the development of autoimmunity responses and reinforces the need for comprehensive safety screening of nanomaterials. Furthermore, these nanomaterials induce pathological processes that mimic those observed in Pleural MM, and therefore require further investigations into their carcinogenicity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Fibrosis in Mesothelioma: Potential Role of Lysyl Oxidases

Lara Perryman, Steven G. Gray

Summary: This article discusses the role of fibrosis in difficult-to-treat cancers and the association of the lysyl oxidase family with fibrosis. It also explores the potential therapeutic effects of drugs targeting lysyl oxidases in the treatment and management of mesothelioma.

CANCERS (2022)

Article Nanoscience & Nanotechnology

Developing Integrated Approaches for Testing and Assessment (IATAs) in order to support nanomaterial safety

L. G. Powell, S. Gillies, T. F. Fernandes, F. Murphy, E. Giubilato, V. Cazzagon, D. Hristozov, L. Pizzol, M. Blosi, A. L. Costa, A. Prina-Mello, H. Bouwmeester, H. Sarimveis, G. Janer, V. Stone

Summary: This article provides guidance for implementing tailored safety assessment strategies for nanomaterials in order to increase their translation from bench development to clinical use. Integrated Approaches to Testing and Assessment (IATAs) are key tools in developing these strategies.

NANOTOXICOLOGY (2022)

Correction Instruments & Instrumentation

Evaluating nanobiomaterial-induced DNA strand breaks using the alkaline comet assay (May, 10.1007/s13346-022-01178-7, 2022)

Melissa Anne Tutty, Gabriele Vella, Antje Vennemann, Martin Wiemann, Adriele Prina-Mello

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2022)

Article Instruments & Instrumentation

Future perspectives for advancing regulatory science of nanotechnology-enabled health products

Blanka Halamoda-Kenzaoui, Robert Geertsma, Joost Pouw, Adriele Prina-Mello, Moreno Carrer, Matthias Roesslein, Adrienne Sips, Klaus Michael Weltring, Kathleen Spring, Susanne Bremer-Hoffmann

Summary: The identification of regulatory challenges for nanotechnology-enabled health products is crucial, and greater collaboration between regulatory and research communities is needed to support regulatory decision-making with academic data. Through cross-sector workshops, common and sector-specific challenges can be identified and solutions can be discussed.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2022)

Article Instruments & Instrumentation

Pre-clinical 2D and 3D toxicity response to a panel of nanomaterials; comparative assessment of NBM-induced liver toxicity

Melissa Anne Tutty, Gabriele Vella, Adriele Prina-Mello

Summary: Nanobiomaterials (NBMs) have wide applications in medicine and bioimaging, but evaluating their safety, especially their impact on the liver, is a challenge. Current pre-clinical methods cannot accurately predict liver toxicity of NBMs. 3D cell culture models provide a more accurate assessment of NBM-tissue interaction.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2022)

Editorial Material Instruments & Instrumentation

REFINE special issue

Kathleen Spring, Klaus-M Weltring, Adriele Prina-Mello, Ruth Schmid

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2022)

Review Chemistry, Analytical

A state of the art in analytical quality-by-design and perspectives in characterization of nano-enabled medicinal products

Thierry Bastogne, Fanny Caputo, Adriele Prina-Mello, Sven Borgos, Muriel Barberi-Heyob

Summary: Quality-by-Design (QbD) is a risk-based and proactive approach widely used in the pharmaceutical field for drug development. Analytical Quality by Design (AQbD) is the adaptation of QbD for analytical method development, aiming to optimize the accuracy and robustness of analysis results. However, there are challenges in understanding and implementing the AQbD approach in practice.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2022)

Article Medicine, General & Internal

Liquid Biopsy: A Multi-Parametric Analysis of Mutation Status, Circulating Tumor Cells and Inflammatory Markers in EGFR-Mutated NSCLC

Martin P. Barr, Anne-Marie Baird, Sophia Halliday, Petra Martin, Emma H. Allott, James Phelan, Greg Korpanty, Linda Coate, Cathal O'Brien, Steven G. Gray, Jane S. Y. Sui, Brian Hayes, Sinead Cuffe, Stephen P. Finn

Summary: Liquid biopsy has the potential to improve patient care in the diagnostic and therapeutic setting in non-small cell lung cancer (NSCLC). It can be used to monitor EGFR mutations and inflammatory markers as prognostic indicators in NSCLC.

DIAGNOSTICS (2022)

Article Biochemistry & Molecular Biology

Discovering Gummadiol and Isoarboreol as potential inhibitors of sphingosine kinase 1: virtual screening and MD simulation studies

Abdelbaset Mohamed Elasbali, Waleed Abu Al-Soud, Hassan H. Alhassan, Afnan Elayyan Mousa Elayyan, Mehnaz Kamal, Hamad Alanazi, Bandar Alharby, Salem Hussain Alharethi, Bashir M. Mohamed

Summary: SphK1 dysfunction is associated with various severe diseases. Small molecule inhibitors with high specificity and efficacy are needed for therapeutic use. Through a structure-based virtual screening, two compounds, Gummadiol and Isoarboreol, were identified as promising inhibitors of SphK1.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

Review Biochemistry & Molecular Biology

Circulating tumour cells: The Good, the Bad and the Ugly

Mark Bates, Bashir M. Mohamed, Mark P. Ward, Tanya E. Kelly, Roisin O'Connor, Victoria Malone, Robert Brooks, Doug Brooks, Stavros Selemidis, Cara Martin, Sharon O'Toole, John J. O'Leary

Summary: This review provides an overview of circulating tumour cells (CTCs), which are highly lethal cancer cells and play a crucial role in cancer metastasis. CTCs have clinical utility as diagnostic, prognostic, and therapeutic targets. However, their complex biology and the challenges involved in their isolation and identification hinder their clinical translation. CTCs are capable of forming microemboli composed of diverse populations, which interact with other circulating cells and may increase their malignant potential. These microemboli represent a prognostically important subset, but the presence of phenotypic gradients adds complexity to the situation.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2023)

Article Biochemistry & Molecular Biology

Integrating network pharmacology approaches for the investigation of multi-target pharmacological mechanism of 6-shogaol against cervical cancer

Abdelbaset Mohamed Elasbali, Waleed Abu Al-Soud, Afnan Elayyan Mousa Elayyan, Ziad H. Al-Oanzi, Hassan H. Alhassan, Bashir M. Mohamed, Hamad H. Alanazi, Mohammad Saquib Ashraf, Shadman Moiz, Mitesh Patel, Mirav Patel, Mohd Adnan

Summary: Traditional cancer treatment faces obstacles such as drug resistance, toxicity, and financial constraints. Phytochemicals that regulate molecular mechanisms are gaining interest as alternative medicine. This study used network pharmacology to explore the regulatory mechanisms of 6-shogaol in cervical cancer treatment. Various databases were screened to identify target genes of 6-shogaol and disease-related targets. Protein-protein interactions and topology analysis identified hub genes. Gene ontology and pathway enrichment analysis were conducted, and molecular docking and survival analysis revealed potential target genes for treatment. The study provides scientific evidence supporting the use of 6-shogaol as a treatment for cervical cancer.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

Article Multidisciplinary Sciences

Proof of concept nanotechnological approach to in vitro targeting of malignant melanoma for enhanced immune checkpoint inhibition

Bandar Alharbi, Husam Qanash, Naif K. K. Binsaleh, Salem Alharthi, Abdulbaset M. M. Elasbali, Chandranil H. H. Gharekhan, Muhammad Mahmoud, Emmanouil Lioudakis, John J. J. O'Leary, Derek G. G. Doherty, Bashir M. M. Mohamed, Steven G. G. Gray

Summary: Immunotherapies, including immune checkpoint inhibitors, have limitations in effectively treating malignancies. Nanotechnology-based platforms for delivering immunotherapeutic agents are being investigated to improve the efficacy of immune checkpoint blockade therapy.

SCIENTIFIC REPORTS (2023)

Article Multidisciplinary Sciences

Ex vivo expansion of circulating tumour cells (CTCs)

Bashir M. Mohamed, Mark P. Ward, Mark Bates, Cathy D. Spillane, Tanya Kelly, Cara Martin, Michael Gallagher, Sheena Heffernan, Lucy Norris, John Kennedy, Feras Abu Saadeh, Noreen Gleeson, Doug A. Brooks, Robert D. Brooks, Stavros Selemidis, Sharon O'Toole, John J. O'Leary

Summary: We developed a new methodology to culture CTCs using primary cancer cells and found that the presence of CTC clusters is essential for long-term culture. This technique will greatly contribute to the development of CTC theranostics.

SCIENTIFIC REPORTS (2023)

Article Multidisciplinary Sciences

Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression

Joanna Lazniewska, Ka Lok Li, Ian R. D. Johnson, Alexandra Sorvina, Jessica M. Logan, Carmela Martini, Courtney Moore, Ben S. -Y. Ung, Litsa Karageorgos, Shane M. Hickey, Sarita Prabhakaran, Jessica K. Heatlie, Robert D. Brooks, Chelsea Huzzell, Nicholas I. Warnock, Mark P. Ward, Bashir Mohammed, Prerna Tewari, Cara Martin, Sharon O'Toole, Laura Bogue Edgerton, Mark Bates, Paul Moretti, Stuart M. Pitson, Stavros Selemidis, Lisa M. Butler, John J. O'Leary, Douglas A. Brooks

Summary: The development and progression of prostate cancer are closely related to the regulation of glucose and lipid metabolism, as well as alterations in androgen receptor expression and signaling. This study reveals a previously unrecognized molecular mechanism for prostate cancer, which involves the dynamic balance between sortilin and syndecan-1 and their impact on different metabolic phenotypes. In androgen-sensitive cells, sortilin enhances glucose metabolism while limiting lipid metabolism, whereas in androgen-insensitive cells, syndecan-1 promotes lipid metabolism. Additionally, androgen-deprived cells show decreased expression of sortilin and increased expression of syndecan-1, contributing to altered glucose and lipid metabolism. These findings have important implications for understanding disease progression and castration-resistant prostate cancer in the context of androgen-deprivation therapy.

SCIENTIFIC REPORTS (2023)

Review Medicine, Research & Experimental

The Current Status and Work of Three Rs Centres and Platforms in Europe*

Winfried Neuhaus, Birgit Reininger-Gutmann, Beate Rinner, Roberto Plasenzotti, Doris Wilflingseder, Joery De Kock, Tamara Vanhaecke, Vera Rogiers, Dagmar Jirova, Kristina Kejlova, Lisbeth E. Knudsen, Rasmus Normann Nielsen, Burkhard Kleuser, Vivian Kral, Christa Thoene-Reineke, Thomas Hartung, Giorgia Pallocca, Costanza Rovida, Marcel Leist, Stefan Hippenstiel, Annemarie Lang, Ida Retter, Stephanie Kraemer, Peter Jedlicka, Katharina Ameli, Ellen Fritsche, Julia Tigges, Eliska Kuchovska, Manuela Buettner, Andre Bleich, Nadine Baumgart, Jan Baumgart, Marcus W. Meinhardt, Rainer Spanagel, Sabine Chourbaji, Bettina Kraenzlin, Bettina Seeger, Maren von Koeckritz-Blickwede, Jose M. Sanchez-Morgado, Viola Galligioni, Daniel Ruiz-Perez, Dania Movia, Adriele Prina-Mello, Arti Ahluwalia, Valeria Chiono, Arno C. Gutleb, Marthe Schmit, Bea van Golen, Leane van Weereld, Anne Kienhuis, Erica van Oort, Jan van der Valk, Adrian Smith, Joanna Roszak, Maciej Stepnik, Zuzanna Sobanska, Edyta Reszka, I. Anna S. Olsson, Nuno Henrique Franco, Bogdan Sevastre, Helena Kandarova, Sara Capdevila, Jessica Johansson, Emma Svensk, Christopher R. Cederroth, Jenny Sandstroem, Ian Ragan, Nataliia Bubalo, Jens Kurreck, Horst Spielmann

Summary: Three Rs centres and platforms are dedicated to the Replacement, Reduction and Refinement of animal use in experiments. They play a crucial role in promoting the implementation of Directive 2010/63/EU and disseminating information.

ATLA-ALTERNATIVES TO LABORATORY ANIMALS (2022)

暂无数据